Sean A. McCarthy, CEO at CytomX Therapeutics, Inc. (CTMX), sold 13,551 shares at $1.38 ($19K) on 2023-12-20, disclosed to the SEC on 2023-12-22.
Seasonal sale ($19k) by CEO — this insider has traded CTMX in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| CTMX | SELL | 2025-11-10 | $924K | — | Filing → |
| CTMX | SELL | 2025-06-17 | $299K | — | Filing → |
| CTMX | SELL | 2025-03-20 | $23K | — | Filing → |